African Flora to Fight Bacterial Resistance, Part I
Standards for the Activity of Plant-Derived Products
- 1st Edition, Volume 106 - February 24, 2023
- Latest edition
- Editor: Victor Kuete
- Language: English
African Flora to Fight Bacterial Resistance, Part One: Standards for the Activity of Plant-Derived Products offers a glimpse into the potential of African medicinal plants to… Read more
Description
Description
African Flora to Fight Bacterial Resistance, Part One: Standards for the Activity of Plant-Derived Products offers a glimpse into the potential of African medicinal plants to fight bacterial infections, with an emphasis on bacterial drug resistance. Sample chapters cover the Global Burden of bacterial infections and drug resistance, Bacterial drug resistance towards natural products, Harvesting and Processing Medicinal plants for antibacterial testing, Screening methods for antibacterial agents from plant source, Established antibacterial drugs from plants, Potential of African medicinal plants against Enterobacteria: classification of plants antibacterial agents, and much more.
Based on collected data, the book offers a rationale classification basis for the antibacterial activity of plant-based products. General knowledge of state-of-the-art of drug resistance is globally described, with the book clearly identifying the best African medicinal plants that could be useful for the development of efficient herbal drugs, as well as the best phytochemicals that could be explored as potential pharmaceuticals.
Key features
Key features
- Provides the first book of its type to focus on the potential of African plants as alternative medicine against bacterial drug resistance
- Analyzes the recorded data to propose a well-elaborated basis for the classification of antibacterial agents from plants
- Clearly identifies and discusses plants and phytochemicals that could be useful in the development of new antibacterial drugs to combat drug resistance
Readership
Readership
Table of contents
Table of contents
Preface
Victor Kuete
1. Global burden of bacterial infections and drug resistance
Hermann Fongang, Armelle T. Mbaveng and Victor Kuete
2. Bacterial drug resistance towards natural products
Armel J. Seukep, Nembo E. Nembu, Helene G. Mbuntcha and Victor Kuete
3. Harvesting and processing medicinal plants for antibacterial testing
Jenifer R.N. Kuete and Victor Kuete
4. Screening methods for antibacterial agents from plant source
Aimé G. Fankam and Victor Kuete
5. Established antibacterial drugs from plants
Armel J. Seukep, Helene G. Mbuntcha, Elizabeth M. Zeuko’o, Luma S. Woquan, Nembo E. Nembu, Francis T. Bomba, Djakissam Watching and Victor Kuete
6. Potential of African medicinal plants against Enterobacteria: Classification of plants antibacterial agents
Victor Kuete
7. African plants acting on Pseudomonas aeruginosa: Cut-off points for the antipseudomonal agents from plants
Simplice B. Tankeo and Victor Kuete
8. Fighting Gram-positive bacteria with African medicinal plants: Cut-off values for the classification of the activity of natural products
Brice E.N. Wamba, Armelle T. Mbaveng and Victor Kuete
9. Potential of African flora to combat tuberculosis and drug resistance of Mycobacteria: Rationale classification of antimycobacterial agents from a natural source
Cedric F. Tchinda and Victor Kuete
10. Anti-Helicobacter pylori activities of African medicinal plants
Paul Nayim, Armelle T. Mbaveng and Victor Kuete
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 106
- Published: February 24, 2023
- Language: English
About the editor
About the editor
VK
Victor Kuete
Professor Victor Kuete is a distinguished Cameroonian scientist and Full Professor of Pharmacognosy at the University of Dschang, where he also serves as Director of the Centre for Study, Research, and Development of Natural Resources and Technologies. His career spans over two decades of groundbreaking research in natural product pharmacology, with a particular focus on African medicinal plants as sources of antimicrobial, antiviral, and anticancer agents. Kuete’s research program emphasizes the mechanisms of action of bioactive compounds, especially against multidrug-resistant (MDR) phenotypes, and has contributed significantly to the global understanding of ethnopharmacology. He has authored more than 500 scientific publications, over 120 book chapters, and several influential books, including Medicinal Plant Research in Africa (2013), Biodiversity, Natural Products and Cancer Treatment (2014), Toxicological Survey of African Medicinal Plants (2014), and African Medicinal Spices and Vegetables (2017). His more recent works, such as African Plants to Fight Bacterial Resistance (2023) and African Plant-Based Products as a Source of Potent Drugs to Overcome Cancers and Their Chemoresistance (2024–2025), further consolidate his reputation as a leading voice in pharmacognosy. Internationally, Kuete has been awarded numerous prestigious fellowships, including TWAS (2007), AUF (2008), DAAD (2009), Alexander von Humboldt (2012–2014, 2015–2018), and Tubitak (2016). These fellowships facilitated collaborations with leading scientists across Europe, Asia, and Africa, strengthening his global research network. His work has been widely cited, with over 26,000 citations and an h-index above 95, placing him among the top 100 African scientists according to the AD Scientific Index. Beyond research, Professor Kuete plays a vital role in mentorship and academic leadership, having supervised dozens of Master’s and PhD theses, many of whose graduates now hold senior academic positions across Africa. He also serves as Editor-in-Chief of Investigational Medicinal Chemistry and Pharmacology, alongside editorial roles in several international journals, reinforcing his influence in shaping the field of ethnopharmacology and drug discovery. Professor Kuete’s career exemplifies the integration of traditional African medicine with modern pharmacological science, positioning him as a global leader in the search for novel therapeutic agents to address pressing health challenges such as cancer, infectious diseases, and drug resistance.